Identification and characterization of HCV replicon variants with reduced susceptibility to HCV-796, and methods related thereto

Details for Australian Patent Application No. 2007286754 (hide)

Owner Wyeth Viropharma Incorporated

Inventors Chopra, Rajiv; Howe, Anita Y. M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007286754

PCT Pub. Number WO2008/024763

Priority 60/840,353 25.08.06 US

Filing date 21 August 2007

Wipo publication date 28 February 2008

International Classifications

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

Event Publications

12 March 2009 PCT application entered the National Phase

  PCT publication WO2008/024763 Priority application(s): WO2008/024763

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007286756-Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds

2007286751-Custom planter and method of custom planting